Clinical Trials on Low-Risk Prostate Cancer
Total 6822 results
-
NHS LothianRecruitingLow Risk Prostate Cancer | Intermediate Risk Prostate Cancer | Localized Prostate CancerUnited Kingdom
-
Institut Paoli-CalmettesJanssen-Cilag Ltd.CompletedLow Risk Prostate CancerFrance
-
Assistance Publique - Hôpitaux de ParisUnité de Recherche Clinique Necker Cochin, FrCompletedLow-Risk Prostate CancerFrance
-
EBG MedAustron GmbHTerminatedLow Risk Prostate Cancer | Intermediate Risk Prostate CancerAustria
-
Henry Ford Health SystemAmerican Cancer Society, Inc.WithdrawnLow or Intermediate Risk Prostate CancerUnited States
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
Istanbul University - CerrahpasaAnkara Yildirim Beyazıt University; Istanbul Training and Research Hospital; Sisli... and other collaboratorsRecruitingLow Risk Prostate Cancer | Clinically Significant Prostate CancerTurkey (Türkiye)
-
Martin T. King, MD, PhDBlue Earth Diagnostics; Dana-Farber/Brigham and Women's Cancer CenterRecruitingProstate Cancer | Intermediate Risk Prostate Cancer | High Risk Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount SinaiActive, not recruitingLow Risk Prostate CancerUnited States
-
Genesis Research LLCTerminatedProstate Cancer | Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance RegimenUnited States
-
Azienda Socio Sanitaria Territoriale degli Spedali...TakedaUnknownIntermediate Risk Prostate Cancer | High Risk Prostate CancerItaly
-
University Health Network, TorontoClinical Laserthermia Systems ABRecruitingProstate Cancer | Low and Intermediate Risk Prostate CancerCanada
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
University Health Network, TorontoClinical Laserthermia Systems AB; Exact ImagingRecruitingProstate Cancer (Adenocarcinoma) | Low and Intermediate Risk Prostate CancerCanada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaActive, not recruitingLow or Intermediate Risk Prostate CancerCanada
-
Heinrich-Heine University, DuesseldorfMedical University of Vienna; KU Leuven; Erasmus Medical Center; Ludwig-Maximilians... and other collaboratorsActive, not recruitingHigh-risk Prostate Cancer | Intermediate-risk Prostate CancerBelgium, Germany, Austria, Switzerland, Sweden, India, Italy
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Copenhagen University... and other collaboratorsRecruitingProstate Cancer Patients Undergoing External Radiation and Seed Implantation | Locally Advanced Prostate Cancer | High Risk Localised Prostate Carcinoma | Unfavourable Intermediate Risk Prostate CancerDenmark
-
Cellvax Therapeutics IncRecruitingProstate Cancer | Prostate Cancer (Adenocarcinoma) | Prostate Cancer Patients Undergoing Radical Prostatectomy | High-risk Prostate Cancer | Prostate CA | Prostate Cancers | Prostate Cancer (Post Prostatectomy)United States
-
Università Vita-Salute San RaffaeleRecruitingLow-Risk Prostate CancerItaly
-
Thomas HopeNovartisRecruitingProstate Cancer | Localized Prostate Carcinoma | Prostate Cancer (Diagnosis) | High-risk Prostate Cancer | Very High Risk Prostate CarcinomaUnited States
-
The Methodist Hospital Research InstituteRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Won KimNovartisTerminated
-
Sunnybrook Health Sciences CentreProstate Cancer CanadaUnknownHIGH RISK PROSTATE CANCERCanada
-
Sergio FariaCompletedHigh Risk Prostate CancerCanada
-
Centre Francois BaclesseTerminatedProstate Cancer With Intermediate RiskFrance
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingNeoadjuvant Therapy | High Risk Prostate Cancer | Locally Advanced Prostate Cancer | Intense Endocrine TherapyChina
-
Hongqian GuoRecruitingNeoadjuvant Therapy \High Risk Prostate CancerChina
-
Hongqian GuoActive, not recruitingNeoadjuvant Therapy \ High Risk Prostate Cancer \ DocetaxelChina
-
University of ChicagoVisualase, Inc.Completed
-
Samsung Medical CenterRecruitingLow-to-intermediate-risk Prostate CarcinomaKorea, Republic of
-
Radboud University Medical CenterNot yet recruitingHigh Risk Localized Prostate Cancer | Synchronous Metastatic Hormone-Sensitive Prostate Cancer
-
General University Hospital, PragueUniversity Hospital Olomouc; Ústřední fakultní vojenská nemocnice, Praha, Czechia and other collaboratorsActive, not recruitingProstate Cancer | High Risk Prostate Cancer | PSMA PET | Staging
-
Turku University HospitalUniversity of TurkuCompleted
-
BayerRecruiting
-
Turku University HospitalActive, not recruitingProstate Cancer | Localized Prostate Carcinoma | Intermediate Risk Prostate Cancer | Castration-Naive Prostate CancerFinland
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingHigh-risk Prostate CancerItaly
-
Rabin Medical CenterRecruitingHigh Risk Prostate CancerIsrael
-
Hospices Civils de LyonUnknown
-
University of OxfordBarinthus BiotherapeuticsTerminatedCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsNot yet recruiting
-
Ostfold Hospital TrustUniversity of TromsoCompletedLow Risk Birth; Births With Low Risk FactorNorway
-
OHSU Knight Cancer InstituteMerck Sharp & Dohme LLC; Oregon Health and Science UniversityWithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | High Risk Prostate Carcinoma | Localized Prostate AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.CompletedProstate Cancer | Prostate Adenocarcinoma | High Risk Prostate CancerUnited States
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedProstate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode MetastasisAustria, Germany
-
Steba Biotech S.A.International Drug Development Institute; PrimeVigilance LTDTerminatedLow Risk Prostate CancerFrance
-
Icahn School of Medicine at Mount SinaiBayer; Merck Sharp & Dohme LLCRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Istituto Clinico Humanitasaccord healthcare italia srlRecruiting
-
Marco OderdaRecruiting
-
Edwin Posadas, MDRecruitingHigh-risk Prostate CancerUnited States